相关实验视频

Updated: Jan 18, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

[肺癌微环境中的加勒-3:免疫调节和治疗突破]

Hongbao Zhu¹, Jiong Deng², Tong Wang¹

¹School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.

Zhongguo fei ai za zhi = Chinese journal of lung cancer

|September 11, 2025

概括

加勒-3驱动肺癌的进展和免疫逃避. 向galectin-3提供了一种有希望的策略,以克服治疗耐药性并改善患者在肺癌免疫治疗中的结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

由于诊断挑战,瘤异质性和治疗耐药性,肺癌的生存率很低.
虽然向疗法和免疫检查点抑制剂显示出有希望的结果,但许多患者发展出耐药性.
加勒-3是一种肺组织中的蛋白质,与瘤进展,免疫逃避和血管生成有关.

研究的目的:

审查肺瘤微环境中的 galectin-3 与免疫细胞相互作用的机制.
评估galectin-3作为克服肺癌治疗耐药性的潜在治疗标.
探索加勒-3抑制剂的开发和组合免疫疗法策略.

主要方法:

科学文献的系统审查.
分析加勒-3在调节瘤细胞增殖,免疫逃避和血管生成中的作用.
对瘤微环境中的T细胞和巨细胞对加勒-3的影响的评估.

主要成果:

加勒-3通过影响免疫逃避和血管生成促进肺癌的进展.
该蛋白与免疫细胞相互作用,导致免疫抑制瘤微环境.
加勒-3 是对当前肺癌疗法的初级和二级耐药性的关键因素.

结论:

加勒-3 是肺癌的重要治疗点.
抑制加勒-3可能会增强现有的免疫疗法的疗效.
向加勒-3提供了一种新的方法来克服治疗耐药性和改善肺癌预后.

关键词:

盖莱克-3 是一种免疫细胞是免疫细胞.肺部瘤是什么肺部瘤瘤细胞是一种瘤细胞.瘤微环境是一个微环境.

更多相关视频

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...